EUCRATES BIOMEDICAL ACQU COR (EUCRW)
Institutional ownership reported to the SEC as of Q1 2023, across 11 quarters.
19
Reporting holders
$52.3K
Reported value
0.0%
Held as options
-2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 19 | $52.3K | 1,364,106 | 4 | 1 | 2 | 0.0% |
| Q4 2022 | 21 | $82.3K | 1,507,749 | 5 | 3 | 3 | 0.0% |
| Q3 2022 | 20 | $70.7K | 1,999,969 | 0 | 1 | 5 | 1.4% |
| Q2 2022 | 21 | $106.0K | 1,974,236 | 4 | 2 | 3 | 1.9% |
| Q1 2022 | 21 | $1.0M | 1,958,659 | 5 | 1 | 3 | 64.6% |
| Q4 2021 | 16 | $973.0K | 1,685,633 | 3 | 1 | 1 | 0.0% |
| Q3 2021 | 15 | $931.0K | 1,261,162 | 1 | 0 | 1 | 0.0% |
| Q2 2021 | 19 | $2.3M | 1,332,203 | 5 | 1 | 2 | 0.0% |
| Q1 2021 | 15 | $2.3M | 1,164,632 | 12 | 0 | 0 | 0.0% |
| Q4 2020 | 4 | $1.1M | 433,331 | 4 | 0 | 0 | 29.6% |
| Q1 2020 | 1 | $13.0K | 10,000 | 1 | 0 | 0 | 0.0% |